Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
PMCID: PMC9917998
How FEHB Premiums are Changing in 2026 While the average enrollee share of premium is going up, not all plans reflect that trend
To date, the FDA has approved only liraglutide and semaglutide for weight loss in the pediatric population
For obesity, NHS-commissioned treatment with semaglutide 2.4mg (Wegovy) is limited to a maximum of two years through specialist services
In a clinical trial of patients with type 2 diabetes, weekly tirzepatide at 5, 10, or 15 mg for 40 weeks resulted in an 8.512.4% weight loss, compared to 6.7% with semaglutide at 1 mg/week [29]
Get personalized weight loss care designed to help you achieve steady, sustainable progress
US$ 27.44
US$ 28.26
US$ 27.28
